— Know what they know.
Not Investment Advice
Also trades as: 5CV.DE (XETRA) · $vol 1M · 5CV.F (FSX) · $vol 0M

CVAC NASDAQ

CureVac N.V.
1W: +7.4% 1M: -13.1% 3M: -16.3% 1Y: +42.6% 3Y: -28.1% 5Y: -95.5%
$4.66
Last traded 2025-12-31 — delisted
NASDAQ · Healthcare · Biotechnology · $1.0B mcap · 96M float · 1.22% daily turnover · Short 32% of daily vol

Cash Flow Trends

Operating Cash Flow
$102M +138.0% ▲
Capital Expenditures
$18M +66.6% ▲
5Y CAGR: +8.6%
Free Cash Flow
$83M +125.8% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$79M +184.9% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$130M-$412M-$249M-$260M$191M
Depreciation & Amort.$11M$16M$24M$23M$19M
Stock-Based Comp.$14M$15M$9M$8M$4M
Change in Working Capital$579M-$70M-$126M-$68M-$164M
Other Non-Cash Items$52M-$481M$57M$29M$52M
Operating Cash Flow$522M-$733M-$286M-$268M$102M
— Investing Activities —
Capital Expenditures-$47M-$128M-$93M-$52M-$14M
Acquisitions (Net)$0$0-$277K$0$0
Investment Purchases-$1M$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$3M-$4M-$5M-$3M-$4M
Investing Cash Flow-$45M-$128M-$93M-$55M-$18M
— Financing Activities —
Net Debt Issuance-$48M-$28M-$4M-$5M-$5M
Stock Repurchased$0-$31M$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$246K$0
Financing Cash Flow$820M$345M$63M$231M-$5M
Net Change in Cash$1.3B-$511M-$316M-$93M$79M
Cash End of Period$1.3B$811M$496M$402M$482M
Free Cash Flow$475M-$861M-$379M-$323M$83M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms